Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2004 Oct;63(10):1312–1317. doi: 10.1136/ard.2003.014175

Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients

R Cervera 1, R Asherson 1, M Acevedo 1, J Gomez-Puerta 1, G Espinosa 1, G de la Red 1, V Gil 1, M Ramos-Casals 1, M Garcia-Carrasco 1, M Ingelmo 1, J Font 1
PMCID: PMC1754783  PMID: 15361392

Abstract

Objective: To describe and analyse the clinical characteristics of 100 patients with antiphospholipid syndrome (APS) associated with infections.

Methods: Patients were identified by a computer assisted search (Medline) of published reports to locate all cases of APS published in English, Spanish, and French from 1983 to 2003. The bilateral Fisher exact test was used for statistics.

Results: 59 female and 41 male patients were identified (mean (SD) age, 32 (18) years (range 1 to 78)): 68 had primary APS, 27 had systemic lupus erythematosus, two had "lupus-like" syndrome, two had inflammatory bowel disease, and one had rheumatoid arthritis. APS presented as a catastrophic syndrome in 40% of cases. The main clinical manifestations of APS included: pulmonary involvement (39%), skin involvement (36%), and renal involvement (35%; nine with renal thrombotic microangiopathy, RTMA). The main associated infections and agents included skin infection (18%), HIV (17%), pneumonia (14%), hepatitis C (13%), and urinary tract infection (10%). Anticoagulation was used in 74%, steroids in 53%, intravenous immunoglobulins in 20%, cyclophosphamide in 12%, plasma exchange in 12%, and dialysis in 9.6%. Twenty three patients died following infections and thrombotic episodes (16 with catastrophic APS). Patients given steroids had a better prognosis (p = 0.024). The presence of RTMA and requirement for dialysis carried a worse prognosis (p = 0.001 and p = 0.035, respectively).

Conclusions: Various different infections can be associated with thrombotic events in patients with APS, including the potentially lethal subset termed catastrophic APS. Aggressive treatment with anticoagulation, steroids, and appropriate antibiotic cover is necessary to improve the prognosis.

Full Text

The Full Text of this article is available as a PDF (85.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abinader A., Hanly A. J., Lozada C. J. Catastrophic antiphospholipid syndrome associated with anti-beta-2-glycoprotein I IgA. Rheumatology (Oxford) 1999 Jan;38(1):84–85. doi: 10.1093/rheumatology/38.1.84. [DOI] [PubMed] [Google Scholar]
  2. Albert L. J., Inman R. D. Molecular mimicry and autoimmunity. N Engl J Med. 1999 Dec 30;341(27):2068–2074. doi: 10.1056/NEJM199912303412707. [DOI] [PubMed] [Google Scholar]
  3. Amital H., Levy Y., Davidson C., Lundberg I., Harju A., Kosach Y., Asherson R. A., Shoenfeld Y. Catastrophic antiphospholipid syndrome: remission following leg amputation in 2 cases. Semin Arthritis Rheum. 2001 Oct;31(2):127–132. doi: 10.1053/sarh.2001.27660. [DOI] [PubMed] [Google Scholar]
  4. Annane Djillali, Sébille Véronique, Charpentier Claire, Bollaert Pierre-Edouard, François Bruno, Korach Jean-Michel, Capellier Gilles, Cohen Yves, Azoulay Elie, Troché Gilles. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002 Aug 21;288(7):862–871. doi: 10.1001/jama.288.7.862. [DOI] [PubMed] [Google Scholar]
  5. Argov S., Schattner A., Burstein R., Handzel Z. T., Shoenfeld Y., Bentwich Z. Autoantibodies in male homosexuals and HIV infection. Immunol Lett. 1991 Sep;30(1):31–35. doi: 10.1016/0165-2478(91)90086-p. [DOI] [PubMed] [Google Scholar]
  6. Asherson R. A. A "primary" antiphospholipid syndrome? J Rheumatol. 1988 Dec;15(12):1742–1746. [PubMed] [Google Scholar]
  7. Asherson R. A., Cervera R., Piette J. C., Shoenfeld Y., Espinosa G., Petri M. A., Lim E., Lau T. C., Gurjal A., Jedryka-Góral A. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 2001 Nov;80(6):355–377. doi: 10.1097/00005792-200111000-00002. [DOI] [PubMed] [Google Scholar]
  8. Asherson R. A., Cervera R., de Groot P. G., Erkan D., Boffa M. C., Piette J. C., Khamashta M. A., Shoenfeld Y., Catastrophic Antiphospholipid Syndrome Registry Project Group Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12(7):530–534. doi: 10.1191/0961203303lu394oa. [DOI] [PubMed] [Google Scholar]
  9. Asherson R. A., Khamashta M. A., Ordi-Ros J., Derksen R. H., Machin S. J., Barquinero J., Outt H. H., Harris E. N., Vilardell-Torres M., Hughes G. R. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989 Nov;68(6):366–374. [PubMed] [Google Scholar]
  10. Asherson R. A., Shoenfeld Y. The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome--molecular mimicry? J Rheumatol. 2000 Jan;27(1):12–14. [PubMed] [Google Scholar]
  11. Asherson R. A. The catastrophic antiphospholipid syndrome. J Rheumatol. 1992 Apr;19(4):508–512. [PubMed] [Google Scholar]
  12. Asherson Ronald A., Shoenfeld Yehuda. Human immunodeficiency virus infection, antiphospholipid antibodies, and the antiphospholipid syndrome. J Rheumatol. 2003 Feb;30(2):214–219. [PubMed] [Google Scholar]
  13. Baid S., Pascual M., Williams W. W., Jr, Tolkoff-Rubin N., Johnson S. M., Collins B., Chung R. T., Delmonico F. L., Cosimi A. B., Colvin R. B. Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nephrol. 1999 Jan;10(1):146–153. doi: 10.1681/ASN.V101146. [DOI] [PubMed] [Google Scholar]
  14. Becker D. M., Saunders T. J., Wispelwey B., Schain D. C. Case report: venous thromboembolism in AIDS. Am J Med Sci. 1992 Jun;303(6):395–397. doi: 10.1097/00000441-199206000-00008. [DOI] [PubMed] [Google Scholar]
  15. Blank Miri, Krause Ilan, Fridkin Mati, Keller Nathan, Kopolovic Juri, Goldberg Iris, Tobar Ana, Shoenfeld Yehuda. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest. 2002 Mar;109(6):797–804. doi: 10.1172/JCI12337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Bloom E. J., Abrams D. I., Rodgers G. Lupus anticoagulant in the acquired immunodeficiency syndrome. JAMA. 1986 Jul 25;256(4):491–493. [PubMed] [Google Scholar]
  17. Brown P., Crane L. Avascular necrosis of bone in patients with human immunodeficiency virus infection: report of 6 cases and review of the literature. Clin Infect Dis. 2001 Mar 26;32(8):1221–1226. doi: 10.1086/319745. [DOI] [PubMed] [Google Scholar]
  18. Cacoub P., Renou C., Rosenthal E., Cohen P., Loury I., Loustaud-Ratti V., Yamamoto A. M., Camproux A. C., Hausfater P., Musset L. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) 2000 Jan;79(1):47–56. doi: 10.1097/00005792-200001000-00005. [DOI] [PubMed] [Google Scholar]
  19. Cailleux N., Marie I., Jeanton M., Lecomte F., Lévesque H., Courtois H. Les anticorps antiphospholipides au cours de l'infection par le virus de l'immunodéficience humaine sont-ils thrombogènes? J Mal Vasc. 1999 Feb;24(1):53–56. [PubMed] [Google Scholar]
  20. Casanova-Román Manuel, Rios Jesús, Sánchez-Porto Antonio, Casanova-Bellido Manuel. Deep venous thrombosis associated with pulmonary tuberculosis and transient protein S deficiency. Scand J Infect Dis. 2002;34(5):393–394. doi: 10.1080/003655402317406914. [DOI] [PubMed] [Google Scholar]
  21. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 11-1990. A 38-year-old woman with fever, skin lesions, thrombocytopenia, and venous thromboses. N Engl J Med. 1990 Mar 15;322(11):754–769. doi: 10.1056/NEJM199003153221108. [DOI] [PubMed] [Google Scholar]
  22. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 18-1999. A 54-year-old woman with acute renal failure and thrombocytopenia. N Engl J Med. 1999 Jun 17;340(24):1900–1908. doi: 10.1056/NEJM199906173402408. [DOI] [PubMed] [Google Scholar]
  23. Chevalier X., Larget-Piet B., Hernigou P., Gherardi R. Avascular necrosis of the femoral head in HIV-infected patients. J Bone Joint Surg Br. 1993 Jan;75(1):160–160. doi: 10.1302/0301-620X.75B1.8421018. [DOI] [PubMed] [Google Scholar]
  24. Cisternas M., Gutiérrez M. A., Rosenberg H., Jara A., Jacobelli S. Catastrophic antiphospholipid syndrome associated with crescentic glomerulonephritis: a clinicopathologic case. Clin Exp Rheumatol. 2000 Mar-Apr;18(2):252–254. [PubMed] [Google Scholar]
  25. Coll Daroca J., Gutiérrez-Cebollada J., Yazbeck H., Bergés A., Rubiés-Prat J. Anticardiolipin antibodies and acquired immunodeficiency syndrome: prognostic marker or association with HIV infection? Infection. 1992 May-Jun;20(3):140–142. doi: 10.1007/BF01704601. [DOI] [PubMed] [Google Scholar]
  26. Creamer D., Hunt B. J., Black M. M. Widespread cutaneous necrosis occurring in association with the antiphospholipid syndrome: a report of two cases. Br J Dermatol. 2000 Jun;142(6):1199–1203. doi: 10.1046/j.1365-2133.2000.03550.x. [DOI] [PubMed] [Google Scholar]
  27. D'Angelo A., Della Valle P., Crippa L., Pattarini E., Grimaldi L. M., Viganò D'Angelo S. Brief report: autoimmune protein S deficiency in a boy with severe thromboembolic disease. N Engl J Med. 1993 Jun 17;328(24):1753–1757. doi: 10.1056/NEJM199306173282405. [DOI] [PubMed] [Google Scholar]
  28. Dalekos G. N., Kistis K. G., Boumba D. S., Voulgari P., Zervou E. K., Drosos A. A., Tsianos E. V. Increased incidence of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti-phospholipid syndrome. Eur J Gastroenterol Hepatol. 2000 Jan;12(1):67–74. doi: 10.1097/00042737-200012010-00013. [DOI] [PubMed] [Google Scholar]
  29. Dalekos G. N., Zachou K., Liaskos C. The antiphospholipid syndrome and infection. Curr Rheumatol Rep. 2001 Aug;3(4):277–285. doi: 10.1007/s11926-001-0031-4. [DOI] [PubMed] [Google Scholar]
  30. Elbeialy A., Strassburger-Lorna K., Atsumi T., Bertolaccini M. L., Amengual O., Hanafi M., Khamashta M. A., Hughes G. R. Antiphospholipid antibodies in leprotic patients: a correlation with disease manifestations. Clin Exp Rheumatol. 2000 Jul-Aug;18(4):492–494. [PubMed] [Google Scholar]
  31. Espinosa Gerard, Santos Eugénia, Cervera Ricard, Piette Jean-Charles, de la Red Gloria, Gil Víctor, Font Josep, Couch Robert, Ingelmo Miguel, Asherson Ronald A. Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients. Medicine (Baltimore) 2003 Mar;82(2):106–118. doi: 10.1097/00005792-200303000-00005. [DOI] [PubMed] [Google Scholar]
  32. Faghiri Z., Wilson W. A., Taheri F., Barton E. N., Morgan O. S., Gharavi A. E. Antibodies to cardiolipin and beta2-glycoprotein-1 in HTLV-1-associated myelopathy/tropical spastic paraparesis. Lupus. 1999;8(3):210–214. doi: 10.1191/096120399678847731. [DOI] [PubMed] [Google Scholar]
  33. Falcini F., Taccetti G., Ermini M., Trapani S., Matucci Cerinic M. Catastrophic antiphospholipid antibody syndrome in pediatric systemic lupus erythematosus. J Rheumatol. 1997 Feb;24(2):389–392. [PubMed] [Google Scholar]
  34. Fiallo P., Nunzi E., Cardo P. P. beta2-Glycoprotein I-dependent anticardiolipin antibodies as risk factor for reactions in borderline leprosy patients. Int J Lepr Other Mycobact Dis. 1998 Sep;66(3):387–388. [PubMed] [Google Scholar]
  35. Fiallo P., Travaglino C., Nunzi E., Cardo P. P. beta 2-Glycoprotein I-dependence of anticardiolipin antibodies in multibacillary leprosy patients. Lepr Rev. 1998 Dec;69(4):376–381. doi: 10.5935/0305-7518.19980038. [DOI] [PubMed] [Google Scholar]
  36. Galli M., Comfurius P., Maassen C., Hemker H. C., de Baets M. H., van Breda-Vriesman P. J., Barbui T., Zwaal R. F., Bevers E. M. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet. 1990 Jun 30;335(8705):1544–1547. doi: 10.1016/0140-6736(90)91374-j. [DOI] [PubMed] [Google Scholar]
  37. Gharavi Azzudin E., Pierangeli Silvia S., Espinola Ricardo G., Liu Xiaowei, Colden-Stanfield Margaret, Harris E. Nigel. Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo. Arthritis Rheum. 2002 Feb;46(2):545–552. doi: 10.1002/art.10130. [DOI] [PubMed] [Google Scholar]
  38. Gharavi E. E., Chaimovich H., Cucurull E., Celli C. M., Tang H., Wilson W. A., Gharavi A. E. Induction of antiphospholipid antibodies by immunization with synthetic viral and bacterial peptides. Lupus. 1999;8(6):449–455. doi: 10.1177/096120339900800607. [DOI] [PubMed] [Google Scholar]
  39. Gibson G. E., Gibson L. E., Drage L. A., Garrett C. R., Gertz M. A. Skin necrosis secondary to low-molecular weight heparin in a patient with antiphospholipid antibody syndrome. J Am Acad Dermatol. 1997 Nov;37(5 Pt 2):855–859. doi: 10.1016/s0190-9622(97)80011-4. [DOI] [PubMed] [Google Scholar]
  40. Giordano P., Galli M., Del Vecchio G. C., Altomare M., Norbis F., Ruggeri L., Petronelli M., de Mattia D. Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia. Br J Haematol. 1998 Sep;102(4):903–906. doi: 10.1046/j.1365-2141.1998.00853.x. [DOI] [PubMed] [Google Scholar]
  41. Greisman S. G., Thayaparan R. S., Godwin T. A., Lockshin M. D. Occlusive vasculopathy in systemic lupus erythematosus. Association with anticardiolipin antibody. Arch Intern Med. 1991 Feb;151(2):389–392. [PubMed] [Google Scholar]
  42. Grinberg A. R., Heller P. G., Correa G., Sarano J. F., Molinas F. C., Nicastro M. A., Alvarez C. L. Síndrome antifosfolipídico catastrófico. Comunicación de dos formas de presentación. Medicina (B Aires) 1999;59(6):743–746. [PubMed] [Google Scholar]
  43. Harris E. N., Gharavi A. E., Boey M. L., Patel B. M., Mackworth-Young C. G., Loizou S., Hughes G. R. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983 Nov 26;2(8361):1211–1214. doi: 10.1016/s0140-6736(83)91267-9. [DOI] [PubMed] [Google Scholar]
  44. Hayem G., Kassis N., Nicaise P., Bouvet P., Andremont A., Labarre C., Kahn M. F., Meyer O. Systemic lupus erythematosus-associated catastrophic antiphospholipid syndrome occurring after typhoid fever: a possible role of Salmonella lipopolysaccharide in the occurrence of diffuse vasculopathy-coagulopathy. Arthritis Rheum. 1999 May;42(5):1056–1061. doi: 10.1002/1529-0131(199905)42:5<1056::AID-ANR27>3.0.CO;2-I. [DOI] [PubMed] [Google Scholar]
  45. Hojnik M., Gilburd B., Ziporen L., Blank M., Tomer Y., Scheinberg M. A., Tincani A., Rozman B., Shoenfeld Y. Anticardiolipin antibodies in infections are heterogenous in their dependency on beta 2-glycoprotein I: analysis of anticardiolipin antibodies in leprosy. Lupus. 1994 Dec;3(6):515–521. doi: 10.1177/096120339400300615. [DOI] [PubMed] [Google Scholar]
  46. Hunt J. E., McNeil H. P., Morgan G. J., Crameri R. M., Krilis S. A. A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus. 1992 Feb;1(2):75–81. doi: 10.1177/096120339200100204. [DOI] [PubMed] [Google Scholar]
  47. Jou I. M., Liu M. F., Chao S. C. Widespread cutaneous necrosis associated with antiphospholipid syndrome. Clin Rheumatol. 1996 Jul;15(4):394–398. doi: 10.1007/BF02230365. [DOI] [PubMed] [Google Scholar]
  48. Kaipiainen-Seppänen O., Leino M. Recurrent uveitis in a patient with juvenile spondyloarthropathy associated with tumour necrosis factor alpha inhibitors. Ann Rheum Dis. 2003 Jan;62(1):88–89. doi: 10.1136/ard.62.1.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Karlsen A. E., Dyrberg T. Molecular mimicry between non-self, modified self and self in autoimmunity. Semin Immunol. 1998 Feb;10(1):25–34. doi: 10.1006/smim.1997.0102. [DOI] [PubMed] [Google Scholar]
  50. Korkmaz C., Harmanci E., Metintaş I., Gülbaş Z. Antiphospholipid syndrome associated with intestinal amoebiasis. Scand J Infect Dis. 2001;33(12):938–940. doi: 10.1080/00365540110076804. [DOI] [PubMed] [Google Scholar]
  51. Koschmieder Steffen, Miesbach Wolfgang, Fauth Florian, Bojunga Joerg, Scharrer Inge, Brodt Hans-Reinhard. Combined plasmapheresis and immunosuppression as rescue treatment of a patient with catastrophic antiphospholipid syndrome occurring despite anticoagulation: a case report. Blood Coagul Fibrinolysis. 2003 Jun;14(4):395–399. doi: 10.1097/00001721-200306000-00011. [DOI] [PubMed] [Google Scholar]
  52. Labarca J. A., Rabaggliati R. M., Radrigan F. J., Rojas P. P., Perez C. M., Ferrés M. V., Acuna G. G., Bertin P. A. Antiphospholipid syndrome associated with cytomegalovirus infection: case report and review. Clin Infect Dis. 1997 Feb;24(2):197–200. doi: 10.1093/clinids/24.2.197. [DOI] [PubMed] [Google Scholar]
  53. Leder A. N., Flansbaum B., Zandman-Goddard G., Asherson R., Shoenfeld Y. Antiphospholipid syndrome induced by HIV. Lupus. 2001;10(5):370–374. doi: 10.1191/096120301669209574. [DOI] [PubMed] [Google Scholar]
  54. Levin M., Eley B. S., Louis J., Cohen H., Young L., Heyderman R. S. Postinfectious purpura fulminans caused by an autoantibody directed against protein S. J Pediatr. 1995 Sep;127(3):355–363. doi: 10.1016/s0022-3476(95)70063-3. [DOI] [PubMed] [Google Scholar]
  55. Loizou S., Cazabon J. K., Walport M. J., Tait D., So A. K. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum. 1997 Jan;40(1):103–108. doi: 10.1002/art.1780400115. [DOI] [PubMed] [Google Scholar]
  56. Maddison P. J., Thorpe C., Seale J. R., Ahmed W., Whiteley G. S. 'Catastrophic' antiphospholipid syndrome. Lupus. 2000;9(7):484–488. doi: 10.1177/096120330000900702. [DOI] [PubMed] [Google Scholar]
  57. Malnick S. D., Abend Y., Evron E., Sthoeger Z. M. HCV hepatitis associated with anticardiolipin antibody and a cerebrovascular accident. Response to interferon therapy. J Clin Gastroenterol. 1997 Jan;24(1):40–42. doi: 10.1097/00004836-199701000-00009. [DOI] [PubMed] [Google Scholar]
  58. Manco-Johnson M. J., Nuss R., Key N., Moertel C., Jacobson L., Meech S., Weinberg A., Lefkowitz J. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr. 1996 Mar;128(3):319–323. doi: 10.1016/s0022-3476(96)70274-3. [DOI] [PubMed] [Google Scholar]
  59. Matsuura E., Igarashi Y., Fujimoto M., Ichikawa K., Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet. 1990 Jul 21;336(8708):177–178. doi: 10.1016/0140-6736(90)91697-9. [DOI] [PubMed] [Google Scholar]
  60. McNeil H. P., Simpson R. J., Chesterman C. N., Krilis S. A. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A. 1990 Jun;87(11):4120–4124. doi: 10.1073/pnas.87.11.4120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Muñoz-Rodríguez F. J., Tàssies D., Font J., Reverter J. C., Cervera R., Sánchez-Tapias J. M., Mazzara R., Ordinas A., Ingelmo M. Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome. J Hepatol. 1999 May;30(5):770–773. doi: 10.1016/s0168-8278(99)80127-5. [DOI] [PubMed] [Google Scholar]
  62. Olguín-Ortega L., Jara L. J., Becerra M., Ariza R., Espinoza L., Wilson W., Barile-Fabris L. Neurological involvement as a poor prognostic factor in catastrophic antiphospholipid syndrome: autopsy findings in 12 cases. Lupus. 2003;12(2):93–98. doi: 10.1191/0961203303lu335oa. [DOI] [PubMed] [Google Scholar]
  63. Olivé A., Queralt C., Sirera G., Centelles M., Force L. Osteonecrosis and HIV infection: 4 more cases. J Rheumatol. 1998 Jun;25(6):1243–1244. [PubMed] [Google Scholar]
  64. Ordi-Ros J., Villarreal J., Monegal F., Sauleda S., Esteban I., Vilardell M. Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome. Clin Diagn Lab Immunol. 2000 Mar;7(2):241–244. doi: 10.1128/cdli.7.2.241-244.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Padovan C. S., Pfister H. W., Bense S., Fingerle V., Abele-Horn M. Detection of Mycoplasma pneumoniae DNA in cerebrospinal fluid of a patient with M. pneumoniae infection-"associated" stroke. Clin Infect Dis. 2001 Oct 5;33(10):E119–E121. doi: 10.1086/323461. [DOI] [PubMed] [Google Scholar]
  66. Peyton B. D., Cutler B. S., Stewart F. M. Spontaneous tibial artery thrombosis associated with varicella pneumonia and free protein S deficiency. J Vasc Surg. 1998 Mar;27(3):563–567. doi: 10.1016/s0741-5214(98)70335-0. [DOI] [PubMed] [Google Scholar]
  67. Prieto J., Yuste J. R., Beloqui O., Civeira M. P., Riezu J. I., Aguirre B., Sangro B. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology. 1996 Feb;23(2):199–204. doi: 10.1002/hep.510230201. [DOI] [PubMed] [Google Scholar]
  68. Puri V., Bookman A., Yeo E., Cameron R., Heathcote E. J. Antiphospholipid antibody syndrome associated with hepatitis C infection. J Rheumatol. 1999 Feb;26(2):509–510. [PubMed] [Google Scholar]
  69. Reitblat T., Drogenikov T., Sigalov I., Oren S., London D. Transient anticardiolipin antibody syndrome in a patient with parvovirus B19 infection. Am J Med. 2000 Oct 15;109(6):512–513. doi: 10.1016/s0002-9343(00)00561-1. [DOI] [PubMed] [Google Scholar]
  70. Rojas-Rodriguez J., Garcia-Carrasco M., Ramos-Casals M., Enriquez-Coronel G., Colchero C., Cervera R., Font J. Catastrophic antiphospholipid syndrome: clinical description and triggering factors in 8 patients. J Rheumatol. 2000 Jan;27(1):238–240. [PubMed] [Google Scholar]
  71. Shoenfeld Y., Blank M., Krause I. The relationship of antiphospholipid antibodies to infections--do they bind to infecting agents or may they even be induced by them? Clin Exp Rheumatol. 2000 Jul-Aug;18(4):431–432. [PubMed] [Google Scholar]
  72. Sthoeger Z. M., Fogel M., Smirov A., Ergas D., Lurie Y., Bass D. D., Geltner D., Malnick S. D. Anticardiolipin autoantibodies in serum samples and cryoglobulins of patients with chronic hepatitis C infection. Ann Rheum Dis. 2000 Jun;59(6):483–486. doi: 10.1136/ard.59.6.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Suárez Ortega S., Artiles Vizcaíno J., Balda Aguirre I., Melado Sánchez P., Arkuch Saade M. E., Ayala Galán E., Betancor León P. La tuberculosis como factor de riesgo de trombosis venosa. An Med Interna. 1993 Aug;10(8):398–400. [PubMed] [Google Scholar]
  74. Tattevin Pierre, Dupeux Sidonie, Hoff Jérome. Leptospirosis and the antiphospholipid syndrome. Am J Med. 2003 Feb 1;114(2):164–164. doi: 10.1016/s0002-9343(02)01365-7. [DOI] [PubMed] [Google Scholar]
  75. Undas A., Swadźba J., Undas R., Musiał J. Trzy epizody ostrej niewydolności wielonarzadowej u chorej z wtórnym zespołem antyfosfolipidowym. Pol Arch Med Wewn. 1998 Dec;100(6):556–560. [PubMed] [Google Scholar]
  76. Uthman I., Tabbarah Z., Gharavi A. E. Hughes syndrome associated with cytomegalovirus infection. Lupus. 1999;8(9):775–777. doi: 10.1191/096120399678841034. [DOI] [PubMed] [Google Scholar]
  77. Uthman I., Taher A., Khalil I. Hughes syndrome associated with varicella infection. Rheumatol Int. 2001 May;20(4):167–168. doi: 10.1007/s002960000086. [DOI] [PubMed] [Google Scholar]
  78. Uthman Imad W., Gharavi Azzudin E. Viral infections and antiphospholipid antibodies. Semin Arthritis Rheum. 2002 Feb;31(4):256–263. doi: 10.1053/sarh.2002.28303. [DOI] [PubMed] [Google Scholar]
  79. Uthman Imad, Taher Ali, Khalil Ismail, Bizri Abdul-Rahman, Gharavi Azzudin E. Catastrophic antiphospholipid syndrome associated with typhoid fever: comment on the article by Hayem et al. Arthritis Rheum. 2002 Mar;46(3):850–850. doi: 10.1002/art.10086. [DOI] [PubMed] [Google Scholar]
  80. Villamil A., Sorkin E., Basta M. C., Mysler E., Macias S., Pekolj J., Ciardullo M., Eleta F., de Santibañes E., Allievi A. Catastrophic antiphospholipid syndrome complicating orthotopic liver transplantation. Lupus. 2003;12(2):140–143. doi: 10.1191/0961203303lu278cr. [DOI] [PubMed] [Google Scholar]
  81. Viseux V., Darnige L., Carmi E., Chaby G., Poulain J. F., Cevallos R., Lok C., Denoeux J. P. Pulmonary embolism and transitory anti-beta2-GPI antibodies in an adult with chicken pox. Lupus. 2000;9(7):558–560. doi: 10.1177/096120330000900716. [DOI] [PubMed] [Google Scholar]
  82. Yamazaki M., Asakura H., Kawamura Y., Ohka T., Endo M., Matsuda T. Transient lupus anticoagulant induced by Epstein-Barr virus infection. Blood Coagul Fibrinolysis. 1991 Dec;2(6):771–774. doi: 10.1097/00001721-199112000-00012. [DOI] [PubMed] [Google Scholar]
  83. Yáez A., Cedillo L., Neyrolles O., Alonso E., Prévost M. C., Rojas J., Watson H. L., Blanchard A., Cassell G. H. Mycoplasma penetrans bacteremia and primary antiphospholipid syndrome. Emerg Infect Dis. 1999 Jan-Feb;5(1):164–167. doi: 10.3201/eid0501.990122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Zhang L., Jacobsson K., Ström K., Lindberg M., Frykberg L. Staphylococcus aureus expresses a cell surface protein that binds both IgG and beta2-glycoprotein I. Microbiology. 1999 Jan;145(Pt 1):177–183. doi: 10.1099/13500872-145-1-177. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES